Our Research
Omniscient Neurotechnology conducts independent and collaborative research with institutions around the world. Using our Quicktome and Infinitome pipelines, we provide insight into neuropathology through advanced brain mapping and connectomic analyses.
Explore our research
Highlighted Publications
Connectomic disturbances underlying insomnia disorder and predictors of treatment response
August 10, 2022
A high powered prospective study comparing healthy individuals and insomnia patients revealed Connectomic changes in the DMN and associated networks underlying the severity of the disorder.
Prehabilitation and rehabilitation using data-driven, parcel-guided transcranial magnetic stimulation treatment for brain tumor surgery: proof of concept case report
May 14, 2022
A case review demonstrating the utility of o8t software alongside neurorehabilitation to assess functional recovery after glioma removal.
Machine Learning Decomposition of the Anatomy of Neuropsychological Deficit in Alzheimer’s Disease and Mild Cognitive Impairment
May 3, 2022
The Hollow Tree Super (HoTS) method was applied to a patient and healthy control group to define parcels and networks corresponding with diagnosis of MCI and Alzheimers.
Eigenvector PageRank difference as a measure to reveal topological characteristics of the brain connectome for neurosurgery
February 4, 2022
An investigation of two graph theory metrics: Eigenvector and PageRank centrality, and how they together inform unique and neurosurgically meaningful topological characteristics of the brain
Connectivity-based parcellation of normal and anatomically distorted human cerebral cortex
November 28, 2021
As the basis for the creation of our patient-specific brain maps, this manuscript unveils the Structural Connectivity Atlas (SCA) methodology
Akinetic mutism reversed by inferior parietal lobule repetitive theta burst stimulation
April 6, 2021
A case study highlighting the benefits of transcranial magnetic stimulation for restoring network functional connectivity in the DMN.
Targeting location relates to treatment response in active but not sham rTMS stimulation
April 1, 2021
A re-opened investigation utilizing o8t atlassing revealed that inaccurate targeting of the dlPFC in veterans reduced treatment response.
Application of structural and functional connectome mismatch for classification and individualized therapy for Alzheimers disease
November 23, 2020
By utilizing the o8t Infinitome processing pipeline, this study revealed connectomic anomalies in the Default Mode Network (DMN) which underpinned the progression of Alzheimer's Disease.
Citing our software
Infinitome Neuroscience Platform:
Omniscient Neurotechnology Pty. Ltd. (o8t) (2020). Infinitome [Computer software]. https://infinitome.o8t.com/. Sydney, Australia.
Quicktome Brain Mapping Platform:
Omniscient Neurotechnology Pty. Ltd. (o8t) (2021). Quicktome [Computer software]. https://quicktome.o8t.com/. Sydney, Australia.